|
Featured Resource
Call me rash... (Sydney Morning Herald)
I find I am turning - yet again - to the subject of my ongoing facial pox. I wouldn't be writing more about it had it not generated the biggest mailbag of any topic I have ever covered in this column.
DUSA Pharmaceuticals to Present at the Friedman Billings Ramsey 2006 Growth Conference (SYS-CON Media)
DUSA Pharmaceuticals, Inc. (NASDAQ NMS: DUSA) announced today that Geoff Shulman, Chairman & CEO and Bob Doman, President & COO, will present at the Friedman Billings Ramsey 2006 Growth Conference. The presentation is scheduled for 11:15 a.m. EDT on Thursday, June 1, 2006 at the Grand Hyatt New York Hotel in New York, NY.
Fougera First-to-Market With Metronidazole Lotion 0.75% (Rx) (PR Newswire via Yahoo! Finance)
Today, specialty pharmaceutical manufacturer Fougera, a division of ALTANA Inc., announced it is first-to-market with FDA-approved Metronidazole Lotion 0.75% . This product is AB-rated to MetroLotion® by Galderma and is indicated for the treatment of rosacea .
DUSA Pharmaceuticals to Present at the Friedman Billings Ramsey 2006 Growth Conference (Market Wire via Yahoo! Finance)
DUSA Pharmaceuticals, Inc. announced today that Geoff Shulman, Chairman & CEO and Bob Doman, President & COO, will present at the Friedman Billings Ramsey 2006 Growth Conference. The presentation is scheduled for 11:15 a.m.
CollaGenex Pharmaceuticals to Present at the FTN Midwest Securities Corporation 2006 Health Care Conference on June 6th (Business Wire via Yahoo! Finance)
NEWTOWN, Pa.----May 26, 2006--CollaGenex Pharmaceuticals, Inc. today announced that Colin Stewart, president and chief executive officer, will present at the FTN Midwest Securities Corp. 2006 Health Care Conference.
|